Filter
4485
Filtered Results: 4485
Text search:
WHO
African
Region
Featured
Recommendations
329
New Publications
1152
Language
Document type
No document type
2522
Studies & Reports
1054
Guidelines
363
Manuals
176
Strategic & Response Plan
161
Fact sheets
74
Training Material
50
Situation Updates
46
Resource Platforms
17
Infographics
17
Brochures
3
Online Courses
2
Countries / Regions
Global
238
Kenya
152
Ethiopia
151
Africa
139
Sierra Leone
137
Liberia
120
Uganda
113
Nigeria
102
Tanzania
96
Ghana
87
South Africa
86
Malawi
85
Congo, Democratic Republic of
72
Rwanda
69
Zambia
65
India
59
Western and Central Europe
58
Guinea
53
Latin America and the Carribbean
52
West and Central Africa
50
Senegal
49
Namibia
49
Syria
47
East and Southern Africa
47
Middle East and North Africa
45
South Sudan
44
Mozambique
44
Nepal
42
Lesotho
40
Burkina Faso
35
Zimbabwe
34
South–East Asia Region
33
Asia
32
Bangladesh
30
Cameroon
29
Central African Republic
26
Myanmar / Burma
25
Botswana
24
Sudan
23
Yemen
23
Ukraine
22
Benin
20
Eswatini/ Swaziland
19
Mali
18
Eastern Europe
18
Somalia
16
Pakistan
16
Afghanistan
16
Indonesia
16
Madagascar
16
Russia
16
Eastern Europe and Central Asia
15
Philippines
14
Haiti
13
Brazil
13
Germany
12
Cambodia
12
Thailand
11
Colombia
11
Côte d’Ivoire / Ivory Coast
10
Venezuela
10
Western Pacific Region
9
Niger
8
Lebanon
8
China
8
Iraq
7
Libya
7
Jordan
6
Chad
6
Papua New Guinea
6
Burundi
6
Vietnam
6
Togo
5
Gambia
5
Angola
5
Mexico
5
Southern Africa
5
North America
5
Guinea-Bissau
4
Palestine
4
Iran
4
Georgia
4
Morocco
3
USA
3
Turkey
3
Egypt
3
North Macedonia
3
Greece
3
Sri Lanka
3
Chile
3
Italy
3
Djibouti
3
Moldova
3
Jamaica
3
Japan
3
Mauritius
3
Tunisia
3
Portugal
3
Saudi Arabia
2
Malaysia
2
Mauritania
2
Argentina
2
Peru
2
Serbia
2
Ecuador
2
Paraguay
2
Albania
2
Armenia
2
Qatar
2
Kyrgyzstan
2
Gabon
2
United Kingdom
2
Spain
2
Bosnia and Herzegovina
2
Vanuatu
1
Dominican Republic
1
Hungary
1
Cape Verde
1
Solomon Islands
1
Poland
1
North Korea
1
Laos
1
Congo-Brazzaville
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Belgium
1
France
1
Norway
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1579
Clinical Guidelines
336
Public Health
280
Women & Child Health
228
Key Resources
189
Capacity Building
68
Pharmacy & Technologies
43
Annual Report MEDBOX
3
Toolboxes
HIV
390
COVID-19
337
Mental Health
288
Planetary Health
225
TB
213
Ebola
211
Rapid Response
164
Disability
158
NTDs
147
AMR
122
Conflict
118
Global Health Education
106
NCDs
101
Refugee
100
Caregiver
79
Pharmacy
56
Health Financing Toolbox
54
Natural Hazards
53
Zika
42
Polio
35
Cholera
27
Social Ethics
15
Specific Hazards
12
South Sudan
2
Typhoon
1
We, the participants at the first-ever International Conference on PEN-Plus in Africa (ICPPA), held on 23– 25 April 2024 in Dar Es Salaam, United Republic of Tanzania, recognize the urgency of the rising burden of noncommunicable diseases (NCDs) a...
The Facilitator's Guide provides instruction and suggestions for teaching the training modules for the Technical Guidelines for Integrated Disease Surveillance and Response in the Africa Region, 2nd...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and .... It often affects people with impaired immunity, including people living with HIV, among whom the most frequent clinical presentation is disseminated histoplasmosis. The symptoms of disseminated histoplasmosis are non-specific and may be indistinguishable from those of other infectious diseases, especially disseminated tuberculosis (TB), thus complicating diagnosis and treatment. Histoplasmosis is one of the most frequent opportunistic infections caused by fungal pathogens among people living with HIV in the Americas and may be responsible for 5–15% of AIDS-related deaths every year in this Region. These guidelines aim to provide recommendations for the diagnosis, treatment, and management of disseminated histoplasmosis in persons living with HIV
The 21st century has witnessed changes - travel and trade, urbanization, environmental degradation and other trends that increase the risk of disease outbreaks, their spread and amplification into epidemics and pandemics. At the same time, the science and knowledge around infectious hazards are cons...
Since the last situation report on the multi-country outbreak of cholera was published on 1 June 2023 (covering data reported until 15 of May), no new country reported a cholera outbreak. In total, 24 countries have reported cases since the beginning of 2023. The ... African Region remains the most affected region with 14 countries reporting cholera cases since the beginning of the year. The overall capacity to respond to the multiple and simultaneous outbreaks continues to be strained due to the global lack of resources, including shortages of the Oral Cholera Vaccine (OCV) and cholera supplies, as well as overstretched public health and medical personnel, who are dealing with multiple parallel disease outbreaks and other health emergencies. Based on the large number of outbreaks and their geographic expansion, as well as a lack of vaccines and other resources, WHO continues to assess the risk at global level as very high.
Since the last situation report on the multi-country outbreak of cholera was published on 6 July 2023 (covering data reported until 15 of June), and as of 15 July 2023, one new outbreak of cholera was reported from India on 15 May 2023. In total, 25 countries have reported cases since the beginning ...
Anaemia is a global public health concern, especially afflicting adolescent girls, women 15–49 years of age, pregnant women, and children in low- and middle-income countries. WHO estimates that in 2019 30% (571 million) of women aged 15–49 years...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
Un évènement de santé publique grave (PHE) consiste en une flambée quelconque ou en toute
autre situation en évolution rapide qui peut avoir un impact négatif sur la santé humaine et exiger
une évaluation et des actions immédiates. Le terme prend en compte tout évènement n’ayant pas
...
This paper looks at the status of tuberculosis (TB) advocacy
communication and social mobilization (ACSM) activities in selected
national TB control programmes in the WHO African .... The
findings are from an assessment of TB ACSM activities in Ghana, Kenya,
Lesotho, Malawi and South Africa.
Disease control, issue 15
The African health monitor
Accessed November 2017
Guidance Note: Mental health and Psychosocial Support Implications of Mpox Outbreaks, September 2024
recommended
The IFRC Psychosocial Centre has published a guidance note providing an overview of the psychosocial consequences of virus outbreaks, with a focus on mpox, and outlines key considerations for MHPSS programming.
The current mpox outbreaks present numerous challenges for responding National Societi...
Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. It is endemic in Asia, Africa, the Americas, and the Mediterranean r.... Worldwide reports include 1.5–2 million new cases each year, more than 300 million at risk of acquiring the disease, and 70,000 deaths per year. Clinical features depend on the Leishmania species and immune response of the host, varying from localized cutaneous disease to visceral form with potentially fatal outcome; however, the common presentation is either cutaneous, mucocutaneous, or visceral leishmaniasis. Many therapeutic agents are being used in Leishmania treatment, but the only effective treatment is achieved with current pentavalent antimonials. WHO considers Leishmaniasis as one of the “Neglected Tropical Diseases” that continues to be prevalent despite international, national, and local efforts towards its control and elimination over the last decade. This chapter reviews the global perspective of Leishmaniasis with increasing recognition of emerging “Atypical forms” and new surge of disease across the world mainly due to increasing conflicts in endemic areas leading to forced migration among other causes. All these challenges related to environment, disease, and vector pose major implications on WHO’s leishmaniasis control and elimination plan.
“We must not forget that no matter where we are or how old we are, we can all work for life and take action.” Francisco Vera, 15, UNICEF Child Advocate
The Young Climate Activists toolkit was created by advocates of all ages who, like you, ar...
he refugee flow to Ethiopia continued during 2018, with 36,1351 persons seeking safety and protection within the country’s borders. At the start of 2019, the nation hosted 905,8312 thousand refugees who were forced to flee their homes as a result ...
There has been a global outbreak of mpox since 2022; this outbreak has been caused by the strain of mpox virus called Clade 2 and has affected around 116 countries worldwide. The current surge in cases is being driven by the rapid spread of a different strain – Clade 1b – which is predominantly ...
PLoSONE 14(9):e0223104.https://doi.org/10.1371/journal.pone.0223104.
The survey centering on reasons behind community resistance was conducted in Butembo in November during a time of Ebola transmission. A researcher from Catholic University of Graben in Butembo and collaborators at the University o...
Rapport biennal de la directrice régionale
The Annual Report summarizes what has been achieved in the year 2022, how WHO supported the country priority, how WHO took the lead in health in bringing together partners to help the country achiev...
This publication articulates the WHO Botswana Country Office’s focus and investment needs for the biennium 2022–2023, building on achievements, networks, and partnerships fostered in 2020-2021.
As the leading health authority within the Unit...
